Crinetics Pharmaceuticals CRNX
NASDAQ CRNX
$84.95 +0.00 (+0.00%)
At close: Sep 2, 2026 · 4:00 PM EDT

Crinetics Pharmaceuticals (CRNX) Prepaid Assets (2017 - 2026)

Crinetics Pharmaceuticals (CRNX) posted quarterly Prepaid Assets of $6.4 million for Q1 2026, down 60.89% year-over-year from $16.4 million in Q1 2025, and down 63.98% quarter-over-quarter from $17.8 million in Q4 2025.

Analysis

Crinetics Pharmaceuticals (CRNX) Prepaid Assets (2017 - 2026) Analysis & Trends

Crinetics Pharmaceuticals' Prepaid Assets history runs 10 years deep, the most recent figure standing at $6.4 million for Q1 2026.

  • In Q1 2026, Prepaid Assets fell 60.89% year-over-year to $6.4 million; the TTM figure through Mar 2026 stood at $6.4 million (down 60.89% YoY), while the FY2025 annual figure was $17.8 million, down 14.31% from the prior year.
  • Prepaid Assets for Q1 2026 stood at $6.4 million, down from $17.8 million in the prior quarter.
  • The five-year high for Prepaid Assets was $20.8 million in Q4 2024, with the low at $448000.0 in Q4 2023.
  • The 5-year median for Prepaid Assets is $3.6 million (2024), against an average of $8.1 million.
  • The sharpest annual moves came in 2022 and 2024: Prepaid Assets slumped 92.73% in 2022, then surged 4547.1% in 2024.
  • Crinetics Pharmaceuticals' Prepaid Assets stood at $1.9 million in 2022, then tumbled by 76.79% to $448000.0 in 2023, then soared by 4547.1% to $20.8 million in 2024, then slipped by 14.31% to $17.8 million in 2025, then slumped by 63.98% to $6.4 million in 2026.
  • Business Quant data shows CRNX's Prepaid Assets at $6.4 million in Q1 2026, $17.8 million in Q4 2025, and $4.8 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Crinetics Pharmaceuticals 8.99 Bn 8.99 Bn 24.96 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 47.69 Mn
Mar 31, 2026 47.18 Mn
Dec 31, 2025 40.17 Mn
Sep 30, 2025 46.92 Mn
Jun 30, 2025 20.40 Mn
Mar 31, 2025 16.43 Mn
Dec 31, 2024 23.65 Mn
Sep 30, 2024 14.92 Mn
Jun 30, 2024 11.82 Mn
Mar 31, 2024 16.27 Mn
Dec 31, 2023 15.60 Mn
Sep 30, 2023 21.11 Mn
Jun 30, 2023 20.28 Mn
Mar 31, 2023 9.28 Mn
Dec 31, 2022 10.76 Mn
Sep 30, 2022 9.96 Mn
Jun 30, 2022 7.78 Mn
Mar 31, 2022 8.52 Mn
Dec 31, 2021 11.01 Mn
Sep 30, 2021 10.65 Mn